Results 271 to 280 of about 208,218 (280)

The High Rate of Bone Resorption in Multiple Myeloma is due to RANK (Receptor Activator of Nuclear Factor-κB) and RANK Ligand Expression

Leukemia and Lymphoma, 2004
Sophie Roux, Xavier Mariette
exaly  

Platelet-derived RANK ligand enhances CCL17 secretion from dendritic cells mediated by thymic stromal lymphopoietin

Platelets, 2015
Takahisa Nakanishi, Muneo Inaba, Akihiro Tanaka   +2 more
exaly  

Human polymorphonuclear neutrophils express RANK and are activated by its ligand, RANKL

European Journal of Immunology, 2012
Birgit Prior, C Wagner, G Maria Hänsch   +2 more
exaly  

Pathophysiology of RANK ligand (RANKL) and osteoprotegerin (OPG)

Annales d'Endocrinologie, 2006
openaire   +2 more sources

Immunohistochemical study of receptor activator of nuclear factor kappa-B ligand (RANK-L) in human osteolytic bone tumors

Journal of Surgical Oncology, 2002
Christopher R Good, Regis J O'Keefe, J Edward Puzas   +2 more
exaly  

Vitamin K2 inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures

Bone, 2000
Yasuhiro Takeuchi, Seiji Fukumoto
exaly  

RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation

Experimental Cell Research, 2007
Kumaran Sundaram, Riko Nishimura
exaly  

Der RANK-Ligand-Antikörper Denosumab als Beispiel der biotechnologischen Medikamentenentwicklung

Osteologie, 2011
R Kocijan
exaly  

Clinical effects of RANK ligand antagonists

Bone, 2012
openaire   +1 more source

Osteoprotegerin, RANK, and RANK ligand: the good, the bad, and the ugly in rheumatoid arthritis.

The Journal of rheumatology, 2001
L C, Hofbauer, A E, Heufelder, R G, Erben   +2 more
openaire   +1 more source